| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1009565043 |
| P356 | DOI | 10.1186/BCR3579 |
| P932 | PMC publication ID | 3978878 |
| P698 | PubMed publication ID | 24274653 |
| P5875 | ResearchGate publication ID | 258921206 |
| P50 | author | Gabriel N Hortobagyi | Q88225186 |
| Wendy A Woodward | Q61037731 | ||
| Daniel Birnbaum | Q64516222 | ||
| P2093 | author name string | Ying Wang | |
| Lajos Pusztai | |||
| Naoto T Ueno | |||
| Keith A Baggerly | |||
| François Bertucci | |||
| Pascal Finetti | |||
| Steven J Van Laere | |||
| Savitri Krishnamurthy | |||
| James M Reuben | |||
| Hiroko Masuda | |||
| Takahiro Kogawa | |||
| Takayuki Iwamoto | |||
| Kazuharu Kai | |||
| Luc Dirix | |||
| Takae Brewer | |||
| W Symmans | |||
| P2860 | cites work | Carcinoma of the breast. III. Results of treatment, 1935-1942 | Q75764087 |
| Determination of oestrogen-receptor status and ERBB2 status of breast carcinoma: a gene-expression profiling study | Q79847215 | ||
| Molecular heterogeneity of inflammatory breast cancer: a hyperproliferative phenotype | Q80209046 | ||
| Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications | Q27860709 | ||
| Molecular portraits of human breast tumours | Q28032461 | ||
| Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies | Q29617680 | ||
| Different gene expressions are associated with the different molecular subtypes of inflammatory breast cancer | Q33942512 | ||
| Relationship between the inflammatory molecular profile of breast carcinomas and distant metastasis development | Q34473935 | ||
| Nuclear factor-kappaB signature of inflammatory breast cancer by cDNA microarray validated by quantitative real-time reverse transcription-PCR, immunohistochemistry, and nuclear factor-kappaB DNA-binding | Q34533007 | ||
| Epidemiology of breast cancer. | Q34570046 | ||
| Epidermal growth factor receptor tyrosine kinase inhibitor reverses mesenchymal to epithelial phenotype and inhibits metastasis in inflammatory breast cancer | Q35007782 | ||
| Triple-negative subtype predicts poor overall survival and high locoregional relapse in inflammatory breast cancer | Q35642344 | ||
| Inflammatory breast cancer: a review | Q36121844 | ||
| Inflammatory infiltrate in invasive lobular and ductal carcinoma of the breast | Q36136011 | ||
| Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition? | Q36197875 | ||
| Molecular and epidemiological characteristics of inflammatory breast cancer in Algerian patients. | Q36587844 | ||
| Genomic and expression analysis of microdissected inflammatory breast cancer | Q36916724 | ||
| Prognostic impact of human epidermal growth factor-like receptor 2 and hormone receptor status in inflammatory breast cancer (IBC): analysis of 2,014 IBC patient cases from the California Cancer Registry | Q37205563 | ||
| Differential response to neoadjuvant chemotherapy among 7 triple-negative breast cancer molecular subtypes | Q37269261 | ||
| Regulation of inflammatory breast cancer cell invasion through Akt1/PKBα phosphorylation of RhoC GTPase | Q39296734 | ||
| Protein kinase CK2 modulates IL-6 expression in inflammatory breast cancer | Q39452921 | ||
| Loss of heterozygosity and its correlation with expression profiles in subclasses of invasive breast cancers | Q42455712 | ||
| Gene expression profiling identifies molecular subtypes of inflammatory breast cancer | Q42475875 | ||
| Identification of cell-of-origin breast tumor subtypes in inflammatory breast cancer by gene expression profiling | Q42485999 | ||
| Uncovering the molecular secrets of inflammatory breast cancer biology: an integrated analysis of three distinct affymetrix gene expression datasets | Q43407097 | ||
| Relapse-free survival in breast cancer patients is associated with a gene expression signature characteristic for inflammatory breast cancer | Q44699346 | ||
| Molecular profiling of inflammatory breast cancer: identification of a poor-prognosis gene expression signature. | Q54696105 | ||
| Differences in survival among women with stage III inflammatory and noninflammatory locally advanced breast cancer appear early | Q63366190 | ||
| Cell kinetics and hormonal receptor status in inflammatory breast carcinoma. Comparison with locally advanced disease. | Q64921032 | ||
| Epidermal growth factor receptor in human breast cancer comparison with steroid receptors and other prognostic factors | Q70872137 | ||
| Prospective study of the prognostic significance of epidermal growth factor receptor in primary breast cancer | Q70997826 | ||
| P433 | issue | 6 | |
| P921 | main subject | inflammation | Q101991 |
| P304 | page(s) | R112 | |
| P577 | publication date | 2013-11-25 | |
| P1433 | published in | Breast Cancer Research | Q2208481 |
| P1476 | title | Comparison of molecular subtype distribution in triple-negative inflammatory and non-inflammatory breast cancers | |
| P478 | volume | 15 |
| Q90161213 | Comparison of molecular profile in triple-negative inflammatory and non-inflammatory breast cancer not of mesenchymal stem-like subtype |
| Q64065201 | Deciphering the role of interferon alpha signaling and microenvironment crosstalk in inflammatory breast cancer |
| Q28075322 | Developmental therapeutics for inflammatory breast cancer: Biology and translational directions |
| Q95660991 | Differential functions of ERK1 and ERK2 in lung metastasis processes in triple-negative breast cancer |
| Q34287510 | Highly adaptable triple-negative breast cancer cells as a functional model for testing anticancer agents |
| Q28552551 | Important Role of FTO in the Survival of Rare Panresistant Triple-Negative Inflammatory Breast Cancer Cells Facing a Severe Metabolic Challenge |
| Q63366138 | Inflammatory breast cancer biology: the tumour microenvironment is key |
| Q50760251 | Inflammatory breast cancer: unique biological and therapeutic considerations. |
| Q37518882 | Macrophages Enhance Migration in Inflammatory Breast Cancer Cells via RhoC GTPase Signaling |
| Q92107432 | NOTCH and DNA repair pathways are more frequently targeted by genomic alterations in inflammatory than in non-inflammatory breast cancers |
| Q55665058 | Outcome of inflammatory breast cancer in Moroccan patients: clinical, molecular and pathological characteristics of 219 cases from the National Oncology Institute (INO). |
| Q34478105 | Overall survival differences between patients with inflammatory and noninflammatory breast cancer presenting with distant metastasis at diagnosis |
| Q47719149 | Pharmacological targeting of GLI1 inhibits proliferation, tumor emboli formation and in vivo tumor growth of inflammatory breast cancer cells. |
| Q36578574 | Photodynamic therapy as an effective therapeutic approach in MAME models of inflammatory breast cancer |
| Q92885772 | Prediction of Bone Metastasis in Inflammatory Breast Cancer Using a Markov Chain Model |
| Q62493703 | Radiomics with artificial intelligence for precision medicine in radiation therapy |
| Q57472306 | Rates of immune cell infiltration in patients with triple-negative breast cancer by molecular subtype |
| Q34145579 | Sub-100nm gold nanomatryoshkas improve photo-thermal therapy efficacy in large and highly aggressive triple negative breast tumors |
| Q36692838 | Tumor-associated macrophages: unwitting accomplices in breast cancer malignancy. |
Search more.